RNXT
RenovoRx, Inc.Company with tickers: RNXT
Market Cap
$42.52M
Shares Outstanding
45,052,706
CIK
1574094
CUSIP
75989R107
Website
Visit website
Investor Relations
Investor relations
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Shaun Bagai | CEO | $1,232,317 |
| Ramtin Agah | — | $692,246 |
| Ronald Kocak | — | $616,696 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Shaun Bagai | CEO | $1,226,050 |
| Leesa Gentry | — | $890,151 |
| Ramtin Agah | — | $603,019 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Shaun Bagai | CEO | $936,779 |
| Angela Gill Nelms | COO | $547,634 |
| Ramtin Agah | — | $506,772 |
| Leesa Gentry | — | — |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Shaun Bagai | CEO | $841,074 |
| Angela Gill Nelms | COO | $707,288 |
| Ramtin Agah | — | $434,655 |